US FDA’s Novel Approvals Peak Near Year-End, Analysis Of Last Decade Suggests
Executive Summary
The Center for Drug Evaluation and Research’s novel approvals concentrated in August, November, and December, while January and June were the slowest months, according to a Pink Sheet analysis of 2014-2023 data.